Update News



Drugs A to Z


Generic Name: Beclomethasone nasal (BE kloe METH a sone)

Brand Names: Beconase AQ, QNASL

Forms: Nasal aerosol with adapter, nasal spray

Qnasl nasal aerosol is compounds of active ingredient as beclomethasone dipropionate, which is an anti-inflammatory steroid. The drug is specifically guided for treating the nasal symptoms related to seasonal and perennial allergic rhinitis in adults and children older than 12 years of age. The drug encompasses beclomethasone, a corticosteroid. It controls the clemency of components in the body which cause inflammation. The drug is available as a non-aqueous nasal spray solution designed mainly for intranasal inhalation.

Drug Description:

The active component of QNASL Nasal Aerosol, is an anti-inflammatory steroid with the chemical name 9-chloro-11╬▓,17,21-trihydroxy-16╬▓methylpregna-1,4-diene-3,20-dione 17, 21-dipropionate.

The solution is a white to almost white, odorless powder with a molecular formula of C28H37ClO7 and a molecular weight of 521.1. It is practically insoluble in water, very soluble in chloroform, and soluble in acetone and in dehydrated alcohol.


The medication is indicated for treating the nasal symptoms referred with seasonal and perennial allergic rhinitis in patients from four years of age and older.


Suggested dosage of the for adults and adolescents approx. 12 years of age or above, is 320 mcg of solution per day as two nasal aerosol sprays in each nostril (80 mcg/aerosol spray) or once daily total maximum dose of four nasal aerosol sprays is recommended safe per day.

The recommended dose for children around 4 to 11 years of age is 80 mcg per day as 1 inclination in each nostril (40 mcg) once daily. Maximum total daily dose of 2 actuations per day is prove safe and healthy.


An overdose of the generic chemical is not expected to generate as risking life symptoms. However, prolonged use of high steroid doses can surpass symptoms such as: thinning skin, easy bruising, changes in the shape or location of body fat (especially in your face, neck, back, and waist), increased acne or facial hair, menstrual problems, impotence, or loss of interest in sex.

Missed Dosage:

Consume the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose. Consuming extra medication will lead to symptoms of over dosage.

Contradictions to the Drug:

The medication is contraindicated in patients with a history of hypersensitivity to beclomethasone dipropionate and/or any other ingredients in QNASL Nasal Aerosol.

Using Guide:

  • Avoid consuming the solution in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label or as prescribed by your doctor so as to gain maximum out of the drug with healthy results.
  • The medication is available with patient instruction guide book for safe use, and directions for priming and disposal of the nasal spray. The formula is for use in the nose only. Do not spray it into your eyes or mouth it may be dangerous.
  • The usual dose is 2 sprays into each nostril once per day. Do not exceed it!
  • The spray must be primed before getting it into use for the first time and if it is left unused for 7 or more days in a row. Do not prime it every day as it is not required.
  • It may take up to 2 weeks to lower or improve your symptoms. Keep using the medication as directed and tell your doctor if your symptoms do not improve after 1 week of treatment.
  • Throw away the nasal spray after you have used 120 sprays, or if the dose indicator shows a zero. Use apt method of disposal pattern. 


Avoid expose of the solution to temperatures higher than 49°C (120°F) as this may cause bursting of the canister. Do not throw the device into a fire or an incinerator. Store the nasal spray at 25°C (77°F); jaunt is permitted between 15° and 30°C (59° and 86°F). Do not puncture the spray or store near heat and open flame. Keep the drug out of reach of children, infant sand pets.

Side Effects:

Adverse events encompassed in combination with administration of nasal spray may include: nasal discomfort; epistaxis; headache but are not limited to above effects only.

Severe symptoms may include: severe or continuous nose bleed; sores in nasal which is too difficult to heal; breathing roughly or heavily, trouble in breathing or snoring; blurred vision, eye pain, or seeing halos around lights; or fever, chills, body aches, flu symptoms.

Less serious side effects may include: sneezing, runny or stuffy nose; unpleasant taste or smell dryness or irritation in your nose or throat; mild itching or rash; or sores or white patches inside or around your nose and nausea, headache, feeling light-headed.

Serious allergic reactions can happen in people getting treated with the spray. Some of those allergic reactions are: Shortness of breath or trouble breathing; skin rash, redness, or swelling; severe itching; swelling of your lips, tongue or face.


Avoid contact of this medication in your eyes. If this does happen, rinse with water and call your doctor. Beclomethasone consumption in patient can lower the blood cells, which plays a vital role in your body by fighting through various infections. Hence it reduces your immunity power, so avoid being near to people who are sick or have certain infections. Consult doctor for preventive treatment if you are exposed to chicken pox or measles. These conditions can be serious or even fatal.

Non-teratogenic Effects: Hypoadrenalism may develop in infants born out of mothers adapted to corticosteroids during pregnancy. Hence, these infants are to be carefully monitored.

Nursing Mothers: Corticosteroids have been found in human breast milk and thus proper care or caution is suggested to be exercised by a nursing mother in consumption of Nasal Aerosol.

Pediatric Use: The safety and effectiveness of Nasal Aerosol spray in children of 4 years and older age have been established. Controlled pediatric clinical trials with this spray contain 909 children 4 to 11 years of age and 188 adolescent patients 12 to 17 years of age.